Skip to main content
. Author manuscript; available in PMC: 2018 Oct 10.
Published in final edited form as: J Am Coll Surg. 2018 Jan 5;226(4):630–637.e1. doi: 10.1016/j.jamcollsurg.2017.12.021

Table 1.

Demographics of BRCA-Mutated and Wild-Type Patients

Variable BRCA (n = 22) Wild-type (n = 105) p Value
Age, y, median (IQR) 61 (57–65) 61 (55–66) 0.990
Male sex, n (%) 14 (64) 48 (46) 0.126
Race, n (%) 0.765
    Caucasian 19 (86) 88 (84)
    Non-Caucasian 3 (14) 17 (16)
History of diabetes, n (%) 6 (27) 25 (24) 0.566
History of smoking, n (%) 6 (27) 29 (28) 0.369
Family history of cancer, n (%)
    Any cancer 14 (64) 64 (61) 0.689
    Pancreatic cancer 2 (9) 13 (12) 0.551
Neoadjuvant therapy, n (%) 5 (23) 17 (16) 0.461
Adjuvant therapy, n (%) 16 (73) 83 (79) 0.648